Nagpur: In a major relief to the Indian travelers, Britain on Tuesday said it would recogonise Covid-19 vaccines which are on the World Health Organisation’s emergency use listing. The list includes China’s Sinovac, Sinopharm and India based Bharat Biotech’s Covaxin.
The changes are said to come in force from November 22 and will benefit fully vaccinated people hailing from Malaysia, United Arab Emirates and India. Those who have taken the jab will not have to self-isolate themselves after arrival in England.
British High Commissioner to India, Alex Ellis took to twitter and said, “More good news for Indian travellers to the UK. From 22 November travellers fully vaccinated with a COVID19 vaccine recognised by WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.”
More good news for 🇮🇳 travellers to 🇬🇧👇
From 22 November travellers fully vaccinated with a #COVID19 vaccine recognised by @WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.https://t.co/UyJsryBd0O https://t.co/mZhaqRgB35— Alex Ellis (@AlexWEllis) November 8, 2021
Bharat Biotech reacting to the development said the emergency use listing approval by WHO “validates the international safety and quality standards of Covaxin.’
The UK government has further simplified the travel rules for all travelers under 18 coming to England. They will be treated as fully vaccinated at the borders and will also be exempted from self-isolation requirements on arrival.
